TEST:

Tumor tissue origin gene detection kit

"In 2023, in order to accelerate the high-quality development of the biomedical industry, Hangzhou City will conduct selection activities in accordance with the relevant requirements of the 'Notice on Organizing the Application for the Recommended Catalog of Innovative and High-quality Hangzhou-made Pharmaceutical Devices'. After the stages of enterprise declaration, district and county preliminary review, and expert review, two products of Canbang Gene Tumor Tissue Origin Gene Detection Kit (PCR Fluorescent Probe Method) and Tumor Tissue Origin Gene Analysis Software were selected as 'Hangzhou Innovative High-quality Hangzhou-made Pharmaceutical Devices' Recommended directory."

"Hangzhou Kebang Gene Technology Co., Ltd. (hereinafter referred to as "Kebang Gene") independently developed the tumor tissue origin gene detection kit (PCR fluorescent probe method) and the tumor tissue origin gene analysis software (hereinafter collectively referred to as "tumor tissue origin") . Genetic testing”) passed the review of the National Medical Products Administration (NMPA), and was officially approved the third-class medical device registration certificate (National Instruments Approval 20223400901, National Instruments Approval 20223210928)."